Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan

<div>Overall survival (OS), GvHD-free survival (GFS), and relapse-free survival (RFS) in acquired aplastic anemia patients: (a) OS was 73.8%, (b) GFS was 63.1%, and (c) RFS was 70.8%.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan 

Figure 1 | Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan 